FeverPAIN score
Authored by Patient infomatics teamOriginally published 8 Feb 2026
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
Medical Professionals
Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our health articles more useful.
The FeverPAIN score is a clinical prediction rule used in primary care to estimate the likelihood of streptococcal pharyngitis in patients presenting with acute sore throat. It is designed to support antibiotic prescribing decisions and reduce unnecessary antimicrobial use.
The score is recommended in UK primary care guidance as part of a structured approach to sore throat assessment.
Clinical use
FeverPAIN is intended for use in acute presentations of sore throat, typically within the first few days of symptom onset. It is most commonly applied in adults and older children presenting to general practice, urgent care, or community settings.
The score estimates the probability of group A beta-haemolytic streptococcal infection and helps stratify patients into groups where antibiotics are unlikely to help, may be considered, or are more likely to be beneficial.
Components of the FeverPAIN score
The score is based on five clinical features. One point is awarded for each criterion present:
Fever during the previous 24 hours.
Purulence, defined as tonsillar exudate.
Attendance within 3 days of symptom onset.
Severely inflamed tonsils.
No cough or coryza.
The total score ranges from 0 to 5.
Interpretation of scores
Lower scores indicate a low likelihood of streptococcal infection, where antibiotics are unlikely to provide meaningful benefit. Higher scores indicate an increasing probability of streptococcal pharyngitis and a greater likelihood of benefit from antibiotic treatment.
As a general guide used in UK practice:
Scores of 0–1 suggest a low risk of streptococcal infection and support a no-antibiotic strategy.
Scores of 2–3 suggest an intermediate risk, where a delayed antibiotic prescription may be appropriate depending on clinical judgement and patient factors.
Scores of 4–5 suggest a higher risk, where immediate antibiotics may be considered.
Thresholds should be applied alongside clinical context and local antimicrobial stewardship guidance.
Evidence base
The FeverPAIN score was developed and validated in UK primary care populations. Studies have shown that its use can reduce immediate antibiotic prescribing without increasing complication rates, while maintaining patient satisfaction.
Compared with other sore throat scoring systems, FeverPAIN incorporates symptom duration and viral features, improving discrimination in early presentations.
FeverPAIN compared with Centor and McIsaac scores
Unlike the Centor score, FeverPAIN includes symptom duration and explicitly accounts for the absence of viral features such as cough or coryza. This makes it particularly useful in early presentations, where decision-making around antibiotics is often most challenging.
In UK primary care, FeverPAIN is generally preferred over Centor-based scores, although both may be encountered in clinical practice.
Role in antimicrobial stewardship
Sore throat is one of the most common reasons for antibiotic prescribing in primary care, despite most cases being self-limiting and viral in origin. The FeverPAIN score supports antimicrobial stewardship by:
Providing an objective framework for prescribing decisions.
Supporting delayed prescription strategies.
Facilitating shared decision-making with patients.
Reducing unnecessary exposure to antibiotics.
Use of the score should be combined with safety-netting advice and clear guidance on when to reconsult.
Limitations and clinical judgement
The FeverPAIN score does not replace clinical judgement. It should be used cautiously in patients with:
Immunosuppression.
Significant comorbidities.
Red flag symptoms such as airway compromise, unilateral swelling, or systemic toxicity.
Recurrent or atypical presentations.
The score is not designed to diagnose complications such as peritonsillar abscess or to guide management in severe systemic illness.
Practical considerations in consultation
Using a structured score can help explain prescribing decisions to patients and may improve acceptance of non-antibiotic management. Documentation of the score can also support clinical governance and audit of antibiotic use.
Clear advice on symptom control, expected illness duration, and red flag symptoms remains essential, regardless of the score.
Patient picks for Infectious disease

Professional
Centor score
The Centor score, and its age-adjusted modification known as the McIsaac score, are clinical prediction tools used to ... In UK practice, these scores are often discussed alongside the FeverPAIN score FeverPAIN score , which is generally preferred in NICE guidance, although Centor-based scores remain widely recognised and used. For this reason,.
by Patient infomatics team

Professional
Coronary artery calcium score
There has been much interest in developing screening methods to identify those at risk of having a primary cardiac event. The coronary artery calcium score (CACS) is considered one such tool and is also used in some cases in the investigation of chest pain. See also the separate articles on Stable Angina Stable angina , Acute Coronary Syndrome.
by Dr Colin Tidy, MRCGP

Professional
CHA₂DS₂-VASc score
The CHA₂DS₂-VASc score is a clinical risk stratification tool used to estimate the risk of stroke and systemic embolism in patients with atrial fibrillation (AF). It is widely used to guide decisions about oral anticoagulation. The score refines earlier risk models by including additional vascular and demographic risk factors and is recommended in.
by Patient infomatics team

Professional
International prostate symptom score
See separat... What is the international prostate symptom score (I-PSS). The International Prostate Symptom Score (I-PSS) is used in the assessment of lower urinary tract symptoms in men (LUTS). International Prostate Symptom Score; Urological Sciences Research Foundation 34586 : IPSS It is reliable, repeatable and has validity and has been.
by Dr Hayley Willacy, FRCGP
Exclusive updates for healthcare professionals
Stay informed with the latest clinical updates, professional insights, and evidence-based guidance. The Patient Pro newsletter curates essential content for healthcare professionals—delivered straight to your inbox.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.
More in infectious disease
- Amoebiasis
- Antenatal infections and their consequences
- Babesiosis
- Balanitis
- Bartonellosis
- Body cavity filariasis
- Genital herpes simplex
- Gonorrhoea
- Hepatitis A
- Leishmaniasis
- Malaria
- Malaria prophylaxis
- Meningitis
- Post-polio syndrome
- Primary HIV infection
- PVL-positive Staphylococcus aureus
- Schistosomiasis
- Staphylococcal scalded skin syndrome
- Tick-borne encephalitis and tick-borne encephalitis vaccination
- Yellow fever and yellow fever vaccination


